Spruce Biosciences Company Insiders

Spruce Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.7692) % which means that it has lost $0.7692 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6793) %, meaning that it created substantial loss on money invested by shareholders. Spruce Biosciences' management efficiency ratios could be used to measure how well Spruce Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of January 6, 2026, Return On Tangible Assets is expected to decline to -1.11. In addition to that, Return On Capital Employed is expected to decline to -1.77. At present, Spruce Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 77.3 M, whereas Net Tangible Assets are forecasted to decline to about 61.8 M. As of January 6, 2026, Common Stock Shares Outstanding is expected to decline to about 543.7 K. In addition to that, Net Loss is expected to decline to about (43.6 M)The market capitalization of Spruce Biosciences is $87.9 Million. 30% of Spruce Biosciences Common outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as Spruce Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Spruce Biosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Spruce Biosciences Workforce Comparison

Spruce Biosciences Insider Trading History

Spruce Biosciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Spruce Biosciences Common often depends on how effective the management is. Spruce Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spruce management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spruce management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Spruce Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spruce Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Spruce Biosciences' management manipulating its earnings.

When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.